| Name | Title | Contact Details |
|---|
iQuantifi is on a mission to revolutionize the way people make financial decisions and act upon them. iQuantifi’s mission is to help people identify, prioritize and achieve their financial goals. Our software platform will provide automated and personalized financial advice to users that will generate intent-based purchases of financial products and services. Our target market consists of people who either do not qualify to work with a financial advisor or the do-it-yourselfer, who prefers to conduct their personal finances themselves.
Consumer retailers in the U.S. are striving to control costs in an environment of decreasing sales/margins and increasing costs/complications of labor. They are being forced by cash-strapped consumers to deliver more with less. This presents an historic opportunity for companies who provide solutions. Retail automation is a high growth market because it addresses the squeeze that customers and consumer retailers are experiencing. The retail automation market segment includes two market sectors; namely consumer-focused retail point of sale automation and consumer-retailer focused supply chain automation. Retail automation is key to the growth of the retail market because of its high quality service offerings. Focused on security, quality of service, and consumer- and retailer-focused value, Automated-X is carving a niche in this rapidly-growing market by providing comprehensive solutions in automated retail. Through QUICKflickUSA, Inc., our wholly-owned subsidiary, the Company has gained a strong entry into the highly attractive business of automated retail. The store-within-a-store concept helps retailers attract more consumers, control inventory, reduce costs, and market products in areas that would be otherwise unavailable. Automated-X plans to move aggressively into other high-growth convenience/price-driven retail automation opportunities.
ChroMedX Corp. is a medical technology company focused on the development of novel, handheld medical devices for diagnostic testing at the patient`s bedside. HemoPalm, the Company`s lead product is the only handheld blood analysis system which combines Blood Gases & Electrolytes with full CO-oximetry. It has a single-use cartridge/handheld reader format, providing the simplest, most rapid and accurate testing process for use in management of critical care patients. Current blood gas systems require purchase of a second device to carry out CO-oximetry measurements. In addition, HemoPalm has the ability to draw capillary blood directly from pin-prick sites into the cartridge, as an alternative to the commonly required, risk-associated arterial blood draws. ChroMedX Corp. technologies are protected by the Company`s issued and pending patents, covering blood/plasma/serum collection, and processing and analysis.
BURST has one simple aim: to make sonic oral care affordable and available to everyone. With the help of the dental community, we`ve crafted an incredible sonic toothbrush that boasts charcoal nano-particle embedded bristles, 33,000 sonic vibrations and an industry leading lithium ion battery that lasts for 4 weeks on just one charge.